PDF herunterladen
Thromb Haemost 1997; 77(03): 605-606
DOI: 10.1055/s-0038-1656016
Letter to the Editor
Schattauer GmbH Stuttgart

An Alternative Method for PAI-1 Promoter Polymorphism (4G/5G) Typing

Authors

  • M Margaglione

    The Unit of Atherosclerosis and Thrombosis, IRCCS “Casa Sollievo della Sofferenza”, S. Giovanni Rotondo, and Institute of Geriatrics, University of Palermo, Italy

  • E Grandone

    The Unit of Atherosclerosis and Thrombosis, IRCCS “Casa Sollievo della Sofferenza”, S. Giovanni Rotondo, and Institute of Geriatrics, University of Palermo, Italy

  • G Cappucci

    The Unit of Atherosclerosis and Thrombosis, IRCCS “Casa Sollievo della Sofferenza”, S. Giovanni Rotondo, and Institute of Geriatrics, University of Palermo, Italy

  • D Colaizzo

    The Unit of Atherosclerosis and Thrombosis, IRCCS “Casa Sollievo della Sofferenza”, S. Giovanni Rotondo, and Institute of Geriatrics, University of Palermo, Italy

  • N Giuliani

    The Unit of Atherosclerosis and Thrombosis, IRCCS “Casa Sollievo della Sofferenza”, S. Giovanni Rotondo, and Institute of Geriatrics, University of Palermo, Italy

  • G Vecchione

    The Unit of Atherosclerosis and Thrombosis, IRCCS “Casa Sollievo della Sofferenza”, S. Giovanni Rotondo, and Institute of Geriatrics, University of Palermo, Italy

  • M d’Addedda

    The Unit of Atherosclerosis and Thrombosis, IRCCS “Casa Sollievo della Sofferenza”, S. Giovanni Rotondo, and Institute of Geriatrics, University of Palermo, Italy

  • G Di Minno

    The Unit of Atherosclerosis and Thrombosis, IRCCS “Casa Sollievo della Sofferenza”, S. Giovanni Rotondo, and Institute of Geriatrics, University of Palermo, Italy
Weitere Informationen

Publikationsverlauf

Received 20. September 1996

Accepted after revision 14. November 1996

Publikationsdatum:
11. Juli 2018 (online)

 als PDF herunterladen  Lizenzen und Reprints
Preview Container
 

  • References

  • 1 Meade TW, Ruddock V, Stirling Y, Chakrabarti R, Miller GJ. Fibrinolytic activity, clotting factors and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study. Lancet 1993; 342: 1076-1079
    CrossrefPubMedSuche in Google Scholar
  • 2 Ridker PM, Hennekens CH, Stampfer MJ, Manson J, Vaughan DE. Prospective study of endogenous tissue plasminogen activator and risk of stroke. Lancet 1994; 343: 0940-0943
    CrossrefPubMedSuche in Google Scholar
  • 3 Chandler WL, Trimble SL, Loo SC, Mornin D. Effect of PAI-1 levels on the molar concentrations of active tissue plasminogen activator (tPA) and tPA/PAI-1 complex in plasma. Blood 1990; 76: 0930-0937
    PubMedSuche in Google Scholar
  • 4 Dawson SJ, Wiman B, Hamsten A, Green F, Humphries S, Henney AM. The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells. J Biol Chem 1993; 268: 10739-10745
    PubMedSuche in Google Scholar